| Name | Age | Level | P1 | P2 | Availability | Years | AFV | Salary | Surplus | Low | Median | High |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Josh Smith | 26 | Majors | UTIL | OF | Medium | 4 | 27.7 | 10.5 | 17.3 | 13.8 | 17.3 | 20.7 |
| Skylar Hales | 22 | Minors | RP | 0 | 0 | 0 | 1.5 | 1.2 | 1.5 | 1.8 |
Total Value:
18.8
| Name | Age | Level | P1 | P2 | Availability | Years | AFV | Salary | Surplus | Low | Median | High |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drew Rasmussen | 29 | Majors | SP | Medium | 2 | 19 | 5 | 14 | 11.2 | 14 | 16.8 | |
| Garrett Cleavinger | 30 | Majors | RP | Medium | 3 | 11.5 | 7 | 4.5 | 3.6 | 4.5 | 5.4 |
Total Value:
18.5
This trade only benefits the Rangers. Smith is a ok player but he can’t play SS and would just be another body added to the already too large group of non-SS infielders the Rays have. On the other hand, Ras is a proven #3 SP (or better) who also can be an elite closer if needed and he’s only expected to get paid $5MM over the next 2 years. He has low trade value because of injury risk but that doesn’t mean the Rays are looking to trade him for a healthy “does nothing to improve the Rays” player. Rays aren’t stupid. They know the demand for Ras at the deadline (if he’s healthy) could easily return them a difference making prospect. They hold off trading him til then.